Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liming Chen

Showing results (551-560 of 575) with videos related to

Pageof 58
Sort By:
The Journal of Dermatological Treatment|February 2, 2026
Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical studyYanting Li, Baohui Yu, Suping Niu, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 2, 2024
A Phase I Clinical Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of GB221 Injection and Trastuzumab (Herceptin<sup>®</sup>) in Healthy Chinese AdultsYu Zhu, Chen Li, Liming Chen, et al.
Nature Communications|January 7, 2023
In vivo detection of bile duct pre-cancer with endoscopic light scattering spectroscopyDouglas K Pleskow, Mandeep S Sawhney, Paul K Upputuri, et al.
The Journal of Biological Chemistry|September 14, 2024
GATA factor TRPS1, a new DNA repair protein, cooperates with reversible PARylation to promote chemoresistance in patients with breast cancerJun Zhang, Yatao Chen, Xue Gong, et al.
Nature Communications|December 13, 2023
A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesityLinong Ji, Hongwei Jiang, Zhifeng Cheng, et al.
Journal of Diabetes|April 24, 2023
Use of basal insulin in the management of adults with type 2 diabetes: An Asia-Pacific evidence-based clinical practice guidelineLinong Ji, Yingying Luo, Yong Mong Bee, et al.
Diabetes|January 25, 2020
Liver ChREBP Protects Against Fructose-Induced Glycogenic Hepatotoxicity by Regulating L-Type Pyruvate KinaseJian-Hui Shi, Jun-Yu Lu, Heng-Yu Chen, et al.
Diabetes/Metabolism Research and Reviews|July 28, 2016
Standards of care for type 2 diabetes in ChinaJianping Weng, Linong Ji, Weiping Jia, et al.
Journal of Diabetes|April 11, 2023
Effectiveness, safety, initial optimal dose, and optimal maintenance dose range of basal insulin regimens for type 2 diabetes: A systematic review with meta-analysisYingying Luo, Jun Xia, Zhan Zhao, et al.
Metabolism: Clinical and Experimental|November 7, 2025
Sphk2 suppresses ferroptosis in ischemic hearts by promoting HSP90AA1-mediated TFEB nuclear translocation, lysosome biogenesis and lysosome-autophagy pathway-dependent lipid-ROS clearanceTing Gong, Danru Wang, Yawei Jin, et al.
Pageof 58

Showing results (551-560 of 575) with videos related to

Sort By:
Pageof 58
The Journal of Dermatological Treatment|February 2, 2026
Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical studyYanting Li, Baohui Yu, Suping Niu, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 2, 2024
A Phase I Clinical Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of GB221 Injection and Trastuzumab (Herceptin<sup>®</sup>) in Healthy Chinese AdultsYu Zhu, Chen Li, Liming Chen, et al.
Nature Communications|January 7, 2023
In vivo detection of bile duct pre-cancer with endoscopic light scattering spectroscopyDouglas K Pleskow, Mandeep S Sawhney, Paul K Upputuri, et al.
The Journal of Biological Chemistry|September 14, 2024
GATA factor TRPS1, a new DNA repair protein, cooperates with reversible PARylation to promote chemoresistance in patients with breast cancerJun Zhang, Yatao Chen, Xue Gong, et al.
Nature Communications|December 13, 2023
A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesityLinong Ji, Hongwei Jiang, Zhifeng Cheng, et al.
Journal of Diabetes|April 24, 2023
Use of basal insulin in the management of adults with type 2 diabetes: An Asia-Pacific evidence-based clinical practice guidelineLinong Ji, Yingying Luo, Yong Mong Bee, et al.
Diabetes|January 25, 2020
Liver ChREBP Protects Against Fructose-Induced Glycogenic Hepatotoxicity by Regulating L-Type Pyruvate KinaseJian-Hui Shi, Jun-Yu Lu, Heng-Yu Chen, et al.
Diabetes/Metabolism Research and Reviews|July 28, 2016
Standards of care for type 2 diabetes in ChinaJianping Weng, Linong Ji, Weiping Jia, et al.
Journal of Diabetes|April 11, 2023
Effectiveness, safety, initial optimal dose, and optimal maintenance dose range of basal insulin regimens for type 2 diabetes: A systematic review with meta-analysisYingying Luo, Jun Xia, Zhan Zhao, et al.
Metabolism: Clinical and Experimental|November 7, 2025
Sphk2 suppresses ferroptosis in ischemic hearts by promoting HSP90AA1-mediated TFEB nuclear translocation, lysosome biogenesis and lysosome-autophagy pathway-dependent lipid-ROS clearanceTing Gong, Danru Wang, Yawei Jin, et al.
Pageof 58